John E. Macor

6.1k total citations
161 papers, 3.2k citations indexed

About

John E. Macor is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, John E. Macor has authored 161 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 77 papers in Organic Chemistry and 50 papers in Cellular and Molecular Neuroscience. Recurrent topics in John E. Macor's work include Receptor Mechanisms and Signaling (30 papers), Synthesis and Biological Evaluation (25 papers) and Neuroscience and Neuropharmacology Research (22 papers). John E. Macor is often cited by papers focused on Receptor Mechanisms and Signaling (30 papers), Synthesis and Biological Evaluation (25 papers) and Neuroscience and Neuropharmacology Research (22 papers). John E. Macor collaborates with scholars based in United States, Germany and India. John E. Macor's co-authors include Kevin Ryan, Edward C. Taylor, Michael E. Newman, B. Kenneth Koe, Gene M. Dubowchik, Edward C. Taylor, James Heym, Lorraine A. Lebel, Ronald J. Post and Robert A. Mack and has published in prestigious journals such as PLoS ONE, Chemical Communications and ACS Catalysis.

In The Last Decade

John E. Macor

159 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John E. Macor United States	29	1.5k	1.3k	691	395	333	161	3.2k
Federico Da Settimo Italy	42	1.9k 1.3×	2.4k 1.9×	570 0.8×	415 1.1×	95 0.3×	210	5.3k
Chris G. Kruse Netherlands	40	1.8k 1.2×	1.9k 1.5×	1.3k 1.9×	956 2.4×	216 0.6×	135	4.5k
Nicola Antonio Colabufo Italy	37	942 0.6×	2.3k 1.8×	837 1.2×	245 0.6×	125 0.4×	183	4.0k
James E. Audia United States	24	561 0.4×	1.6k 1.2×	432 0.6×	337 0.9×	280 0.8×	64	3.1k
Nicholas I. Carruthers United States	36	889 0.6×	1.7k 1.3×	659 1.0×	191 0.5×	199 0.6×	102	4.2k
Alfredo Cagnotto Italy	31	702 0.5×	1.5k 1.2×	731 1.1×	327 0.8×	131 0.4×	113	3.4k
Péter Mátyus Hungary	28	1.4k 0.9×	1.3k 1.0×	397 0.6×	213 0.5×	54 0.2×	184	2.9k
Patrick R. Verhoest United States	25	1.0k 0.7×	1.7k 1.3×	506 0.7×	690 1.7×	128 0.4×	56	3.4k
Sabrina Taliani Italy	36	1.2k 0.8×	1.8k 1.4×	490 0.7×	268 0.7×	83 0.2×	145	3.6k
Neal Castagnoli United States	28	649 0.4×	909 0.7×	1.0k 1.5×	349 0.9×	153 0.5×	74	3.4k

Countries citing papers authored by John E. Macor

Since Specialization

Citations

This map shows the geographic impact of John E. Macor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Macor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Macor more than expected).

Fields of papers citing papers by John E. Macor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Macor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Macor. The network helps show where John E. Macor may publish in the future.

Co-authorship network of co-authors of John E. Macor

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Macor. A scholar is included among the top collaborators of John E. Macor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Macor. John E. Macor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Korvorapun, Korkit, Thomas Maier, Armin Bauer, et al.. (2023). Site-Selective C–H Functionalization of N-Aryl and N-Heteroaryl Piperidines, Morpholines, and Piperazines Controlled by a Chiral Dirhodium Tetracarboxylate Catalyst. ACS Catalysis. 13(4). 2359–2366. 9 indexed citations

Hart, Amy C., Lynn M. Abell, Junqing Guo, et al.. (2019). Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage. ACS Medicinal Chemistry Letters. 11(3). 266–271. 31 indexed citations

Civiello, Rita L., Xiaojun Han, Brett R. Beno, et al.. (2016). Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines. Bioorganic & Medicinal Chemistry Letters. 26(4). 1229–1232. 4 indexed citations

Wu, Yong‐Jin, Ramkumar Rajamani, Jeremy H. Toyn, et al.. (2016). Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(23). 5729–5731. 14 indexed citations

Engers, Darren W., Anna L. Blobaum, Rocco D. Gogliotti, et al.. (2016). Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu₄). ACS Chemical Neuroscience. 7(9). 1192–1200. 39 indexed citations

Li, Yu-Wen, Matthew A. Seager, Karen Heman, et al.. (2015). Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy. Neuropharmacology. 102. 121–135. 15 indexed citations

Zuev, Dmitry, Li Xu, Kimberley A. Lentz, et al.. (2015). Design and optimization of tricyclic gamma-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 26(5). 1498–1502. 11 indexed citations

Wu, Yong‐Jin, Yunhui Zhang, Weixu Zhai, et al.. (2015). Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE). Bioorganic & Medicinal Chemistry Letters. 25(22). 5040–5047. 13 indexed citations

Luo, Guanglin, Ling Chen, Charles M. Conway, et al.. (2012). Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine. ACS Medicinal Chemistry Letters. 3(4). 337–341. 32 indexed citations

10.

Zuev, Dmitry, Ronald J. Mattson, Hong Huang, et al.. (2011). Potential CRF1R PET imaging agents: N-Fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines. Bioorganic & Medicinal Chemistry Letters. 21(8). 2484–2488. 16 indexed citations

11.

Hartz, Richard A., Vijay T. Ahuja, William D. Schmitz, et al.. (2010). Synthesis and structure–activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(6). 1890–1894. 16 indexed citations

12.

Degnan, Andrew P., Charles M. Conway, Deborah A. Cook, et al.. (2008). Discovery of (R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): A Potent Antagonist of the Human Calcitonin Gene-Related Peptide Receptor for Migraine with Rapid and Efficient Intranasal Exposure. Journal of Medicinal Chemistry. 51(16). 4858–4861. 53 indexed citations

13.

Macor, John E., et al.. (2004). A Chiral Synthesis of (−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘- oxazolidin-2‘-one]: A Conformationally Restricted Analogue of Acetylcholine That Is a Potent and Selective α7 Nicotinic Receptor Agonist. The Journal of Organic Chemistry. 69(19). 6493–6495. 24 indexed citations

14.

Ruel, Réjean, Timothy F. Herpin, Lawrence G. Iben, et al.. (2003). β-Alanine dipeptides as MC4R agonists. Bioorganic & Medicinal Chemistry Letters. 13(24). 4341–4344. 17 indexed citations

15.

Macor, John E., David H.A. Blank, Carol B. Fox, et al.. (1995). 5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl] benzimidazole (CP-161,242): A potent, centrally active 5-HT1D receptor agonist and benzodiazepine partial agonist. Bioorganic & Medicinal Chemistry Letters. 5(20). 2391–2396. 1 indexed citations

16.

Brown, David, Paul Butler, Peter Ellis, et al.. (1995). The in vivo pharmacological profile of a 5‐HT₁ receptor agonist, CP‐122, 288, a selective inhibitor of neurogenic inflammation. British Journal of Pharmacology. 116(5). 2385–2390. 32 indexed citations

17.

Koe, B. Kenneth, Jann A. Nielsen, John E. Macor, & James Heym. (1992). Biochemical and behavioral studies of the 5‐HT_1B receptor agonist, CP‐94,253. Drug Development Research. 26(3). 241–250. 95 indexed citations

18.

Macor, John E., et al.. (1992). 1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors. Journal of Medicinal Chemistry. 35(20). 3625–3632. 19 indexed citations

19.

Macor, John E., Ronald J. Post, & Kevin Ryan. (1992). A synthesis of 5‐carboxamidopyrrolo[3,2‐b]pyridine. Journal of Heterocyclic Chemistry. 29(6). 1465–1467. 1 indexed citations

20.

Taylor, Edward C. & John E. Macor. (1986). Further intramolecular reactions of 1,2,4-triazines. Synthesis of furo[2,3-]pyridines and dihydropyrano[2,3-]pyridines. Tetrahedron Letters. 27(4). 431–432. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact